603990.SH
麦迪科技
SSE · Healthcare · Medical - Healthcare Information Services · CN
CNY 22.75
−0.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 299.8M | 301.5M | 464.1M | 618.1M | 305.5M |
| Cost of Revenue | 121.1M | 119.3M | 400.7M | 497.7M | 90.1M |
| Gross Profit | 178.7M | 182.2M | 63.4M | 120.5M | 215.5M |
| Operating Expenses | |||||
| R&D Expense | 28.2M | 28.6M | 51.2M | 50.0M | 47.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 70.5M | 72.3M | 150.7M | 196.7M | 61.4M |
| Selling & Marketing Expense | 65.9M | 65.1M | 77.0M | 74.8M | 61.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 170.6M | 175.2M | 351.9M | 367.5M | 174.0M |
| Cost and Expenses | 291.7M | 294.5M | 752.7M | 865.2M | 264.1M |
| Operating Income (EBIT) | 24.0M | 45.9M | (253.3M) | (261.9M) | 44.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 23.9M | 45.4M | (253.7M) | (262.0M) | 43.6M |
| Income Tax Expense | 3.1M | 3.9M | 23.9M | 3.3M | 8.1M |
| Bottom Line | |||||
| Net Income | 19.4M | 39.2M | (279.5M) | (269.4M) | 33.6M |
| Earnings from Cont. Ops | 18.2M | 47.9M | (34.2M) | 15.4M | 35.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 19.4M | 39.2M | (279.5M) | (269.4M) | 33.6M |
| Per Share | |||||
| Basic EPS | CN¥0.06 | CN¥0.13 | (CN¥0.92) | (CN¥0.88) | CN¥0.12 |
| Diluted EPS | CN¥0.06 | CN¥0.13 | (CN¥0.92) | (CN¥0.88) | CN¥0.12 |
| Revenue Per Share | CN¥0.78 | CN¥1.00 | CN¥1.53 | CN¥2.02 | CN¥1.09 |
| Shares | |||||
| Basic Shares Outstanding | 384.6M | 301.2M | 303.8M | 306.2M | 279.7M |
| Diluted Shares Outstanding | 384.6M | 301.2M | 303.8M | 306.2M | 279.7M |
| Profitability Metrics | |||||
| EBITDA | — | 72.4M | (179.0M) | (229.5M) | 59.5M |
| D&A | — | 26.5M | 74.3M | 32.4M | 15.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026